Summary
For Year 2026-27, Anthem Biosciences reports the following shareholding: Total Promoters at 74.68%, Mutual Fund at 10.12%, Insurance at 0.93%, Foreign Institutional Investors at 1.28%, Domestic Institutional Investors at 0.5%, and Retail at 12.49%. This breakdown provides a quick snapshot of ownership distribution for Anthem Biosciences in 2026-27.
Anthem Biosciences FAQs
As of 05-2026, the promoter shareholding in Anthem Biosciences stands at 74.68% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Anthem Biosciences is 1.28% and 0.5% respectively.
The retail shareholding of the Anthem Biosciences is 12.49%.
Changes in shareholding patterns of Anthem Biosciences can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Anthem Biosciences are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
